Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
3.32 Down 0.12(3.49%) Apr 24, 4:00PM EDT
Add to Portfolio
Prev Close:3.44
Open:3.43
Bid:3.35 x 2000
Ask:3.79 x 500
1y Target Est:7.00
Beta:2.72
Earnings Date:May 11 - May 15 (Est.)
Day's Range:3.32 - 3.47
52wk Range:1.94 - 5.48
Volume:1,010,125
Avg Vol (3m):2,017,320
Market Cap:391.22M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IDRADown 3.49%391.22M
DVAXDown 1.60%674.27M
PFEDown 0.25%216.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5,552.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.46
Quarterly EPS Est (Mar-15) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for oncology and rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback